Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Transplantation
Journal
Overview
Identity
Overview
Publication Venue For
Risk Prediction for Delayed Allograft Function: Analysis of the Deterioration of Kidney Allograft Function (DeKAF) Study Data
. 106:358-368.
2022
P.162: Enhancing Islet Allotransplantation With Antioxidant-based Encapsulation Strategies
. 105:S69.
2021
Peribiliary intravascular fibrin occlusions and bile duct necrosis in DCD livers during ex situ perfusion: Prevention with tissue plasminogen activator and fresh frozen plasma
. 105:E401-E402.
2021
Early Outcomes With the Liver-kidney Safety Net
. 105:1261-1272.
2021
Prediction of Organ Donation After Circulatory Death: In Search of a Better Crystal Ball
. 105:1165-1166.
2021
What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?
. 105:1143-1155.
2021
B Cells Break Maternal T-Cell Tolerance of Fetal Antigen
. 1637-1638.
2021
Cardiac Mortality following Kidney Transplantation: Progress Made but Still Room for Improvement
. 278-279.
2021
Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes
. 436-442.
2021
Early Kidney Allograft Failure after Simultaneous Liver-kidney Transplantation: Evidence for Utilization of the Safety Net?
. 816-823.
2021
Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion
. 2132-2134.
2021
Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States
. 1904-1908.
2021
Thirty Years of Tacrolimus in Clinical Practice
. 484-495.
2021
A Video Intervention to Increase Organ Donor Registration at the Department of Motorized Vehicles
. 104:788-794.
2020
Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living-donor Kidney Transplantation
. 122-129.
2020
Geographic differences in population health and expected organ supply in the Gulf Coast Region of the United States compared to non-Gulf States
. 421-427.
2020
Global transplantation COVID report march 2020
. 1974-1983.
2020
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
. 1215-1228.
2020
Late Graft Loss after Kidney Transplantation: Is "death with Function" Really Death with a Functioning Allograft?
. 1483-1490.
2020
Social determinants of health: Going beyond the basics to explore racial disparities in kidney transplantation
. 1324-1325.
2020
Life-supporting Kidney Xenotransplantation from Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens
. 103:2090-2104.
2019
Center variation and risk factors for failure to complete 6 month postdonation follow-up among obese living kidney donors
. 103:1450-1456.
2019
Ethnic and age disparities in outcomes among liver transplant waitlist candidates
. 103:1425-1432.
2019
Establishing a core outcome measure for life participation: A standardized outcomes in nephrology-kidney transplantation consensus workshop report
. 103:1199-1205.
2019
Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation
. 102:2080-2087.
2018
Intraoperative Management of Liver Transplant Patients Without the Routine Use of Renal Replacement Therapy
. 102:e229-e235.
2018
Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants
. 102:471-477.
2018
Patient and Kidney Allograft Survival in Recipients with End-Stage Renal Disease from Amyloidosis
. 102:300-309.
2018
Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up
. 102:135-139.
2018
A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient.
. 101:1461-1467.
2017
Cost-effectiveness of antibody-based induction therapy in deceased donor kidney transplantation in the United States
. 101:1234-1241.
2017
Long-Term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation
. 100:1294-1298.
2016
APOL1 genotype and kidney transplantation outcomes from deceased african American donors
. 100:194-202.
2016
Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipients
. 100:141-146.
2016
The kidney-vascular-bone axis in the chronic kidney disease-mineral bone disorder
. 100:497-505.
2016
Center-level variation in the development of delayed graft function after deceased donor kidney transplantation
. 99:997-1002.
2015
Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients
. 99:805-810.
2015
Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: A Markov decision process model
. 99:360-366.
2015
Donor-derived transmission events in 2013: A report of the organ procurement transplant network Ad Hoc disease transmission advisory committee
. 99:282-287.
2015
Islet size index as a predictor of outcomes in clinical islet autotransplantation
. 97:1286-1291.
2014
The authors' reply
. 97.
2014
Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria
. 97:1043-1048.
2014
Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients
. 97:846-853.
2014
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients
. 97:446-450.
2014
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation
. 98:857-863.
2014
Order of donor type in pediatric kidney transplant recipients requiring retransplantation
. 96:487-493.
2013
Hepatitis C virus infection in heart transplantation: Is ventricular assist device therapy an option?
. 96.
2013
Outcomes in systemic sclerosis-related lung disease after lung transplantation
. 95:975-980.
2013
Erratum: Is decedent race an independent predictor of organ donor consent or merely a surrogate marker of socioeconomic status (Transplantation (2012) 2:94 (873))
. 95.
2013
Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage
. 95:48-53.
2013
Is decedent race an independent predictor of organ donor consent or merely a surrogate marker of socioeconomic status?
. 94:873-878.
2012
Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients
. 93:1075-1085.
2012
Reply to "genetic determinants of mycophenolate-related anemia and leukopenia after transplantation"
. 93.
2012
Total lymphoid irradiation in heart transplantation: Long-term efficacy and survival-an 18-year experience
. 92:1159-1164.
2011
African American living-kidney donors should be screened for apol1 risk alleles
. 92:722-725.
2011
Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation
. 92:759-766.
2011
Gene polymorphisms impact the risk of rejection with hemodynamic compromise: A multicenter study
. 91:1326-1332.
2011
Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation
. 91:309-316.
2011
Novel polymorphisms associated with tacrolimus trough concentrations: Results from a multicenter kidney transplant consortium
. 91:300-308.
2011
Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: Results from a multicenter study
. 90:1099-1105.
2010
Evidence for antibody-mediated injury as a Major determinant of late kidney allograft failure
. 90:68-74.
2010
Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms
. 87:1801-1806.
2009
ABO incompatible renal transplantation: A paradigm ready for broad implementation
. 87:1246-1255.
2009
Adenovirus infection activates akt1 and induces cell proliferation in pancreatic islets1
. 87:821-824.
2009
Erratum: Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin (Transplantation (1999) 68:11 (1660-1673))
. 86:482.
2008
Erratum: Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients (Transplantation (1999) 68:2 (215-219))
. 86:482.
2008
Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: A multi-institutional study
. 85:1632-1639.
2008
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts
. 85:935-942.
2008
Retraction: Peritransplant tolerance induction with anti-CD3-immunotoxin: A matter of proinflammatory cytokine control (Transplantation (1998) 65, 9, (1159-1169))
. 85:920.
2008
ABO-incompatible transplantation: Less may be more
. 84.
2007
The impact of left ventricular systolic dysfunction on survival after renal transplantation
. 84:1610-1617.
2007
Factors affecting graft survival after liver transplantation from donation after cardiac death donors
. 82:1683-1688.
2006
Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome
. 82:501-507.
2006
High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation
. 81:1141-1146.
2006
Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil
. 80:1174-1180.
2005
The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome
. 80:1019-1025.
2005
Mycophenolate mofetil: Ten years of clinical experience. Introduction
. 80.
2005
Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: An alternative for type 1 primary hyperoxaluria
. 80:421-424.
2005
United Network for Organ Sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data [4]
. 79:623.
2005
Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways
. 79:409-418.
2005
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: A report from the Israel penn international transplant tumor registry
. 78:1676-1682.
2004
Two-dose daclizumab induction therapy in 209 liver transplants: A single-center analysis
. 78:1212-1217.
2004
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma
. 78:972-977.
2004
Leflunomide therapy for cytomegalovirus disease in renal allograft recepients
. 77:1460-1461.
2004
Right donor nephrectomy: A comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approaches
. 77:521-525.
2004
West Nile virus encephalitis in organ transplant recipients: Another high-risk group for meningoencephalitis and death?
. 77:466-469.
2004
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation
. 76:1583-1588.
2003
Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis
. 76:650-656.
2003
Donors with central nervous system malignancies: Are they truly safe?
. 76:340-343.
2003
Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro
. 76:237-243.
2003
Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isoiated human pancreatic islets
. 76:252-261.
2003
MALToma: A Helicobacter pylori-associated malignancy in transplant patients: A report from the Israel Penn International Transplant Tumor Registry with a review of published literature
. 75:225-228.
2003
Bone mineral density changes within six months of renal transplantation
. 75:49-54.
2003
Bone mineral density changes within six months of renal transplantation.
. 75:49-54.
2003
Liver transplant-associated graft-versus-host disease
. 75:118-126.
2003
Maximizing renal artery length in right laparoscopic donor nephrectomy by retrocaval exposure of the aortorenal junction
. 75:83-85.
2003
17β-estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: Molecular mechanisms and islet functionality
. 74:1252-1259.
2002
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders
. 74:1090-1095.
2002
Simvastatin induces activation of the serine-threonine protein kinase Akt and increases survival of isolated human pancreatic islets
. 74:1063-1069.
2002
The nondirected live-kidney donor: Ethical considerations and practice guidelines. A national conference report
. 74:582-589.
2002
Chlamydia pneumoniae respiratory infection after allogeneic stem cell transplantation
. 73:1002-1005.
2002
An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells
. 72:954-956.
2001
Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection
. 71:1772-1776.
2001
Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up
. 71:1681-1683.
2001
The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenografts
. 70:1667-1674.
2000
A differential requirement for CD8
+
donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells
. 70:1068-1073.
2000
Long-term results of liver transplantation in patients 60 years of age and older
. 70:780-783.
2000
Significance of blood stream infection after lung transplantation: Analysis in 176 consecutive patients
. 69:2360-2366.
2000
The safety and efficacy of a two-dose daclizumab (Zenapax) induction therapy in liver transplant recipients
. 69:1867-1872.
2000
Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrow
. 69:1020-1022.
2000
Posttransplant lymphoproliferative disorder localized near the allograft in renal transplantation
. 69:809-814.
2000
Hepatopulmonary syndrome and venous emboli causing intracerebral hemorrhages after liver transplantation: A case report
. 68:1809-1811.
1999
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: A phase II trial
. 68:1526-1532.
1999
Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: Results of the U.S. multicenter FK506 kidney transplant study group
. 68:1203-1205.
1999
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation
. 68:663-671.
1999
Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection
. 68:310-313.
1999
Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients
. 68:215-219.
1999
Screening by tRNA primer extension analysis of porcine kidney mRNA libraries defines a novel endogenous porcine retroviral long terminal repeat
. 67:1391-1395.
1999
Immunoregulatory role of CD8alpha in the veto effect.
. 67:372-380.
1999
Immunoregulatory role of CD8α in the veto effect: Transforming growth factor-b1 activation
. 67:372-380.
1999
Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process?
. 66:1300-1306.
1998
PRIMARY NONFUNCTION: IS IT DUE TO IMPAIRED MITOCHONDRIAL AT SYNTHESIS?
. 66:S8-S8.
1998
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients
. 66:507-515.
1998
Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation
. 66:29-37.
1998
Peritransplant tolerance induction with anti-CD3 immunotoxin: A matter of proinflammatory cytokine control
. 65:1159-1169.
1998
Long-term outcome of patients transplanted with livers from hepatitis C- positive donors
. 65:925-929.
1998
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation (multiple letters)
. 65:142-145.
1998
Mycophenolate mofetil for the treatment of a first acute renal allograft rejection
. 65:235-241.
1998
Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation
. 65:180-187.
1998
A molecular epidemiological probe for pig microchimerism
. 64:347-350.
1997
Split tolerance induced by immunotoxin in a rhesus kidney allograft model
. 63:1339-1345.
1997
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation
. 63:977-983.
1997
Immunolocalization of acidic fibroblast growth factor and receptors in the tubulointerstitial compartment of chronically rejected human renal allografts
. 63:988-995.
1997
FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts
. 63:1-6.
1997
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection
. 62:594-599.
1996
Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection
. 62:467-475.
1996
Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection
. 62:190-200.
1996
Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model
. 61:1222-1228.
1996
Molecular conjugate-mediated gene transfer into isolated human kidneys
. 61:812-817.
1996
Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection
. 61:722-729.
1996
Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3 - A randomized, double-blind placebo-controlled study
. 61:573-577.
1996
Impact of donor/recipient size matching on outcomes in renal transplantation
. 61:383-388.
1996
Gas-generating systems in acute renal allograft rejection in the rat: Co-induction of heme oxygenase and nitric oxide synthase
. 61:93-98.
1996
Pretransplant status and patient survival following liver transplantation
. 60:920-925.
1995
Evaluation of living renal donors: The current practice of US transplant centers
. 60:322-327.
1995
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
. 60:225-232.
1995
Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy
. 60:138-144.
1995
A rapid flow cytometry assay for hla antibody detection using a pooled cell panel covering 14 serological crossreacting groups
. 59:626-630.
1995
The predictive value of hepatocyte glycogen content on liver allograft biopsy: Correlation with early graft function
. 59:141-143.
1995
Renal retransplantation: The role of race, quadruple immunosuppression, and the flow cytometry cross-match
. 57:47-54.
1994
The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443)
. 57:640-643.
1994
Immunosuppressive therapy as a determinant of transplantation outcomes
. 55:1297-1305.
1993
OKT3 rescue for steroid-resistant rejection in adult liver transplantation
. 55:87-91.
1993
Regulation of cytokine-stimulated vascular cell adhesion molecule-1 expression in renal tubular epithelial cells
. 55:172-177.
1993
Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression
. 53:103-109.
1992
Proliferation of cytomegalovirus-primed lymphocytes in bronchoalveolar lavages from lung transplant patients
. 54:635-639.
1992
Rs-61443—a phase i clinical trial and pilot rescue study
. 53:428-432.
1992
The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list
. 53:363-368.
1992
The impact of the UNOS mandatory sharing policy on recipients of the black and white races-experience at a single renal transplant center
. 53:770-774.
1992
Cytomegalovirus hemorrhoiditis in cardiac allograft recipients
. 51:918-920.
1991
Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients
. 51:70-75.
1991
Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples
. 52:1109-1110.
1991
Survival of ganciclovir-treated heart transplant recipients with cytomegalovirus pneumonitis
. 52:910-913.
1991
Exquisite sensitivity of dendritic cells to ultraviolet radiation and temperature changes
. 48:666-671.
1989
Functional and morphological studies of long-term islet allografts in the renal subcapsular space of the BB/W rat
. 47:580-582.
1989
Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera: Race, transplant history, and HLA-DR1 phenotype
. 47:240-245.
1989
Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients
. 47:66-71.
1989
Donor-specific transfusions in renal transplantation in children effect of azathioprine plus transfusions
. 44:159-161.
1987
Effect of low-temperature culture and site of transplantation on hamster islet xenograft survival (Hamster to mouse)
. 44:465-468.
1987
Primary integumentary allograft reactivity in the American cockroach, periplaneta Americana
. 43:514-519.
1987
Lethal Graft-Vkrsus-Host disease in a recipient of a pancreas-spleen transplant
. 41:544-546.
1986
Prolonged survival of donor skin grafts on mice bearing established islet of langerhans transplants
. 40:216-218.
1985
Primary integumentary xenograft reactivity in the american cockroach, periplaneta Americana
. 37:478-484.
1984
Reactivity of lymphocyte cytotoxic autoantibodies from renal patients with cell line K562
. 38:557-558.
1984
Possibility of graft-vs-leukemia determinants independent of the major histocompatibility complex in allogeneic marrow transplantation
. 35:378-385.
1983
Successful renal transplantation despite warm B cell antibodies
. 36:207-209.
1983
Qa-1-associated antigens: IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition
. 34:54-59.
1982
Fatal response suggestive of graft-versus-host reaction following transplantation of spleen cells from allogeneic athymic (Nude) donors
. 31:201-204.
1981
Improved renal function using adenosine triphosphate-magnesium chloride in preservation of canine kidneys subjected to warm ischemia
. 31:187-189.
1981
Exponential relationship between spleen cell concentration and fatal graft-versus-host response after transplantation of allogeneic spleen-marrow cell mixtures
. 29:507-510.
1980
Percutaneous transluminal dilation in renal transplant arterial stenosis
. 30:440-444.
1980
Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.
. 28:443-446.
1979
Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation
. 27:443-450.
1979
Ia and H-2 antigens on blast cells
. 19:528-530.
1975
Identity
International Standard Serial Number (issn)
0041-1337
Electronic International Standard Serial Number (eissn)
1534-6080